Bayer

Bayer first company to advance cell therapy as well as gene therapy against Parkinson’s disease

22 Sep 2025

First European Participants Randomized in AskBio Phase 2 Gene Therapy Trial of AB-1005 for Parkinson’s Disease

22 Sep 2025

First Parkinson’s disease patient treated in BlueRock’s pivotal Phase III trial of investigational cell therapy bemdaneprocel

22 Sep 2025

Elinzanetant recommended for approval in EU as treatment of moderate to severe vasomotor symptoms

19 Sep 2025

Bayer initiates auditor rotation process

12 Sep 2025

Bayer launches Bayer Co.Lab AdVenture platform in China to accelerate access to global investment network enhancing biotech innovation

12 Sep 2025

Bayer to present research on sleep disturbances associated with menopause at the World Sleep congress 2025

03 Sep 2025

Data from Phase III VICTOR clinical trial of vericiguat presented at ESC Congress 2025

01 Sep 2025

Gadoquatrane New Drug Application Accepted for Review by U.S. FDA

01 Sep 2025

Bayer Foundation and United Nations Capital Development Fund partner on new investment vehicle for food systems enterprises

26 Aug 2025

View details about the software product Informachine News Trackers